Serial changes in levels of IL-6 and IL-1β in premature infants at risk for bronchopulmonary dysplasia

Pediatric Pulmonology

Volumn 31, Issue 3, 2001, Pages 220-226

  Kazzi, S Nadya J ^a,c   Romero, Roberto ^a   McLaughlin, Kathleen ^b   Ager, Joel ^a   Janisse, James ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c HUTZEL HOSPITAL   (United States)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Cytokines; Inflammatory mediators; Neonatal lung inflammation; Neonatology; Prematurity

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LUNG SURFACTANT EXTRACT;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GESTATIONAL AGE; HUMAN; INFLAMMATION; LUNG DYSPLASIA; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL; REGRESSION ANALYSIS;

BRONCHOPULMONARY DYSPLASIA; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; LUNG; MALE; RISK FACTORS;

EID: 0035085288     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.1032     Document Type: Article

References (39)

1. Pathophysiology of lung injury and repair: Special features of the immature lung
2. Tracheal lavage and plasma fibronectin: Relationship to respiratory distress syndrome and development of bronchopulmonary dysplasia
3. Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia
4. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance
5. Elastase and αI-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia
6. Increased activity of interleukin-6 but not tumor necrosis factor-α in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia
7. Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia
8. Increase in interleukin (IL)-1β and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity
9. Early increase of TNFα and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants
10. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia
11. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops
12. Association of pulmonary inflammation and increased microvascular permeability during the development of BPD: A sequential analysis of inflammatory mediators in respiratory fluids of high risk preterm neonates
13. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in broncho alveolar lavage fluid from premature infants who develop chronic lung disease
14. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: A possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns
15. Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity
16. Increased soluble ICAM-1 in tracheal aspirates of infants with bronchopulmonary dysplasia
17. Soluble L-selectin concentration in broncho alveolar lavage fluid obtained from infants who develop chronic lung disease of prematurity
18. Markers and mediators of inflammation in neonatal lung disease
19. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia
20. Dexamethasone therapy in neonatal chronic lung disease: An international placebo-controlled trial
21. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease
22. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome
23. Open randomized controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants
24. Early dexamethasone - Attempting to prevent chronic lung disease
25. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome
26. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant treated infants
27. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: A randomized trial
28. Effects of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant
29. Comparison of secretory component for immunoglobulin A with albumin as reference proteins in tracheal aspirate from preterm infants
30. Cell polarity regulates the release of secretory component, the epithelial receptor for polymeric immunoglobulins from the surface of HT-29 colon carcinoma cells
31. Neonatal interleukin-1β, interleukin-6, and tumor necrosis factor: Cord blood levels and cellular production
32. Maternal and neonatal plasma cytokine levels in relation to mode of delivery
33. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia
34. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model
35. Characterization of Exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses
36. Immunosuppressive properties of surfactant and plasma on alveolar macrophages
37. Systematic review and metaanalysis of early postnatal dexamethasone for prevention of chronic lung disease
38. Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants
39. Early dexamethasone therapy in preterm infants: A follow-up study